S

Sobi

Develops therapies for rare diseases

Associate – Director Global Business Development

Corporate StrategyConfirmed live in the last 24 hours
Full-timeShanghai, ChinaNo salary listed

About the Job

Requirements

  • A track record across the deal lifecycle—including sourcing, evaluation, valuation, and diligence—from international pharma (ideally in a global strategy, commercial, or global research and development role), top-tier consulting, healthcare banking, equity research, venture capital, or private equity; typically 6–10+ years, scaling with level.
  • Exceptional analytical and quantitative ability, with strong scientific, clinical, commercial, and financial judgment.
  • Strong working knowledge of global drug development and commercialisation, as well as the China biopharma environment, with an established network.
  • An MD or PhD in a Life Science field is required.
  • Fluency in English and Mandarin.
  • Based in Shanghai or willing to relocate to Shanghai.

Responsibilities

  • Proactively identify, map, and prioritize China-originated in-licensing, acquisition, and co-development opportunities in Haematology, Immunology, and Specialty Care; generate proprietary deal flow through continuous coverage of emerging companies, clinical pipelines, the CDE registry, and NMPA developments.
  • Personally lead end-to-end evaluations and turn complex inputs into a clear, defensible investment view.
  • Lead analytical diligence across research and development, Medical Affairs, Commercial, Market Access, and Finance; build and own valuations reflecting deal economics, including licenses, option structures, joint ventures, and acquisitions.
  • Produce decision-ready business cases to support board-level recommendations; support the structuring of priority transactions with Corporate Development and Legal.
  • Build senior relationships across biotech, investors, banks, and advisors to gain early, differentiated access.

About the Company

Sobi

Develops therapies for rare diseases

Sobi specializes in developing and delivering therapies for rare diseases. It focuses on hematology, immunology, and specialty care, bringing medicines to patients who have limited treatment options. Their products are designed to treat rare conditions and are typically administered by prescription under medical supervision; the company collaborates with partners to advance research, develop, and commercialize these therapies. Sobi differentiates itself through its strong biotechnological foundation from its Biovitrum heritage and a track record of strategic collaborations with major pharmaceutical players like Sanofi and Apellis, which expand its research capabilities and reach. The company’s goal is to improve the lives of patients with rare diseases worldwide by creating and delivering effective treatments that address unmet medical needs.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Solna kommun, Sweden
Founded
1988

Recently Posted Jobs

Explore more opportunities at Sobi

See more jobs